NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Gastroenterology Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gastroenterology Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Colorectal Cancer



Colorectal cancers with altered beta-catenin produce excess securin



August 7th, 2006

Colorectal cancers with altered beta catenin produce excess securin.

According to a study from Germany, "Overexpression of the transcriptional activator beta-catenin, mostly owing to loss-of-function mutations of the adenomatous polyposis coli (APC) tumor suppressor gene, is crucial for the initiation and progression of human colorectal carcinogenesis."

"Securin is a regulator of chromosome separation and its overexpression has been shown to be involved in different tumour-promoting processes, like transformation, hyperproliferation and angiogenesis, and correlates with tumor cell invasion," said F. Hlubek and colleagues, University of Munich.

...


Source: Gastroenterology Week (2006-08-07)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login